Dexamethasone therapy and rates of secondary pulmonary and bloodstream infections in critically ill COVID-19 patients.

Autor: Rothe, Kathrin1 (AUTHOR) Kathrin.Rothe@mri.tum.de, Lahmer, Tobias2 (AUTHOR) Tobias.Lahmer@mri.tum.de, Rasch, Sebastian2 (AUTHOR) Sebastian.Rasch@mri.tum.de, Schneider, Jochen2 (AUTHOR) jochen.schneider@mri.tum.de, Spinner, Christoph D.2 (AUTHOR) christoph.spinner@mri.tum.de, Wallnöfer, Fabian2 (AUTHOR) fabian.wallnoefer@mri.tum.de, Wurst, Milena2 (AUTHOR) milena.wurst@mri.tum.de, Schmid, Roland M.2 (AUTHOR) rolandm.schmid@mri.tum.de, Waschulzik, Birgit3 (AUTHOR) Birgit.Waschulzik@mri.tum.de, Fuest, Kristina4 (AUTHOR) kristina.fuest@tum.de, Kriescher, Silja4 (AUTHOR) silja.kriescher@tum.de, Schneider, Gerhard4 (AUTHOR) g.schneider@tum.de, Busch, Dirk H.1 (AUTHOR) dirk.busch@mri.tum.de, Feihl, Susanne1 (AUTHOR) susanne.feihl@tum.de, Heim, Markus4 (AUTHOR) m.heim@tum.de
Zdroj: Multidisciplinary Respiratory Medicine. 12/29/2021, Vol. 16, p1-7. 7p.
Databáze: Academic Search Ultimate